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Summary 
We analyzed the T cell receptor (TCR) rearrangements of 100 TCR-adfl CD4-CDS-  (double 
negative [DN]) T cell clones from normal individuals. We found that in four out of six donors 
this subset contains expanded clones that often account for 0.5%  and, in one individual, even 
7% of all peripheral blood lymphocytes. By combining limiting dilution analysis and N region 
oligotyping of polymerase chain reaction amplified TCR cDNA, we could measure the clonal 
size and show that two of these expanded clones remain stable in size for up to 4 yr in peripheral 
blood. The expanded clones analyzed ex vivo are not cycling and CD45 RA  hi RO l~ but express 
high levels of cx4/fll integrins, suggesting that they may have reverted to resting cells after activation. 
One of these expanded DN clones proliferates in vitro in response to Escherichia coli presented 
by monocytes cultured in GM-CSF plus IL-4 and kills CDla + Molt-4 cells. In contrast to what 
was found in the ot/fl DN subset, cx/fl CD4 + T cell clones specific for a tetanus toxin epitope 
showed a very small clonal size (<1 in 107) and could not be reisolated after 2 yr. Taken together, 
these results indicate that large clonal size and persistence are distinctive features of c~/fl DN 
cells specific for bacterial antigens. These cells may use antigen-presenting cells, restriction molecules, 
and selection routes different from those used by antigen-specific CD4 + T  cells. 
T 
he majority of mature TCR-cx/3 T cells express either 
the CD4 or CD8 coreceptor which participates in both 
recognition of the MHC-peptide complex and T cell activa- 
tion (for a review see reference 1). A minor subset of ot/fl 
T cells that is double negative (DN)* for CD4 and CD8 has 
been described in the thymus and in the periphery of mice 
and humans (2,  3).  This subset differs  in many properties 
from the cx/3 CD4 + or CD8 + single positive (SP) T cells. 
First,  it is not clear whether oe/fl DN cells are thymus 
derived. Indeed, in the thymus, this subset appears  late in 
ontogeny after cr/3 SP cells (2, 4). In addition, it has been 
reported that they can differentiate in bone marrow or liver 
of euthymic, athymic, or thymectomized mice (5-7). Second, 
mouse cx/fl DN cells do not follow the rules of negative and 
positive selection that apply to SP cells. Indeed, they express 
a restricted repertoire, which contains potentially autoreac- 
tive Vfl segments (7, 8) or autoreactive TCR. that are deleted 
in SP cells of the same animal (9, 10). In addition, ae/fl DN 
1 Abbreviations used in this paper: DN,  double negative; LDA,  limiting 
dilution assay; SP, single positive; TT, tetanus toxoid. 
cells do not contain increased levels of Vfl that are positively 
selected in SP cells (8). Although the potential autoreactivity 
of the oe/3 DN subset has never been directly proven, they 
are greatly expanded in the list and gld autoimmune mouse 
strains (11), where they accumulate as resting cells in LNs, 
after proliferation in the liver (12). In humans, oe/fl DN cells 
have been found expanded up to 50%  of peripheral blood 
in patients with autoimmune diseases (13,  14). Third, cx/3 
DN have unique growth requirements, since they proliferate 
in response to IL-3 (3,  15). 
There is no consensus on the specificity and restriction of 
ol/3 DN T cells. It has been shown in the mouse that these 
cells increase in number after intraperitoneal injection of bac- 
teria (16). Porcelli et al. (17) have reported that some human 
ot/fl DN clones recognize CDla molecules. In addition, the 
same group has recently reported that some cx/B DN clones 
respond in vitro to mycobacterial antigens presented by CDlb 
molecules, indicating that this cell subset may have unique 
restriction specificities  (18). 
All these results suggest that the repertoire and lifestyle 
of cr/3 DN T  cells may differ from SP T  cells.  Thus,  we 
were interested to establish the clonal make-up of this subset 
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independent o~/~ DN clones isolated from the same donor 
carried the same patterns of TCR-/3 and -3' rearrangements, 
suggesting that they may have derived from the same clone 
that  was  expanded in vivo. 
We have developed a method based on PCR oligotyping 
which allows us to quantitate and monitor a clonotype and 
show that ot/~ DN T  cells comprise expanded clones that 
can account for 0.5-7% of all peripheral blood mononuclear 
cells.  One of these expanded clones specific for Escherichia 
coli persists for at least 4 yr and displays a phenotype in vivo 
that is noncycling, ot4/B1 integrin high, CD45RA hi RO l~ 
Materials and Methods 
Cell Cultures.  T  cells were cloned and maintained according 
to established methods (19). Stimulation ofT cells in limiting dilu- 
tion with antigen was performed according to reference 20.  For 
antigen presentation experiments, peripheral blood adherent cells 
were expanded in vitro as described by Porcelli et al. (18) in RPMI 
10% FCS supplemented with 50 ng/ml human recombinant GM- 
CSF and 500 U/ml human recombinant Ib4. When collected after 
6-8 d, "~60% of these cells were large, nonadherent with a typical 
veiled appearance,  and expressed high levels of CDla, CDlb, and 
CDlc and low levels of CD14. These cells were mitomycin C treated 
and 2  x  104 were cultured with 3  x  104 cells from cr  DN 
clones in 200 #1 RPMI  10% FCS in the presence or absence of 
heat-killed E. coli (JM109 strain)  and anti-CD1 antibodies (1:200 
dilution of ascites).  T  cell proliferation was measured after 40 h 
by thymidine incorporation. Cytotoxicity was performed according 
to standard methods (21). 
Cell Staining.  PBMC were stained with mouse mAb 10A12 (3'2a 
anti-CD4),  OKT8 (3"2a anti-CD8),  and WT31 (3/1 anti-CD3/ 
TCR-cff~), followed by goat anti-mouse 3"2a FITC plus anti yl 
PE antisera (southern Biotechnology Associates, Birmingham, AL). 
The WT31 +, CD4-  CD8- cells were sorted on a FACStar Plus | 
(Becton Dickinson  &  Co.,  Mountain  View,  CA),  immediately 
cloned by limiting dilution at 0.2 cells per well (50-80% e~ciency), 
and expanded using irradiated allogeneic PBMC, PHA, and human 
rlL2. For three-color FACS  |  analysis, purified PBMC were stained 
with biotin-WT31, FITC-anti Leu2a (CDS), and FITC-anti Leu3a 
(CD4), plus.one of the following antibodies: PE-anti-DR, PE-anti- 
CD25,  PE-anti-Leu17  (CD38),  PE-anti-Leu8  (Lam-1)  (Becton 
Dickinson & Co.), PE-UCHL1 (anti-CD45R0) (Dako Corp., Car- 
pinteria, CA), PE-2H4.RD1 (anti-CD45RA) (Coulter Corp., Hi- 
aleah, FL), K20 (anti-CD29, mouse 3'2a), HP2/1 (anti-very late 
antigen [VLA]4, mouse 1) (Immunotech, Marseille, France), anti- 
CD69 (mouse/~, a gift of Dr. C. Cosulich, IST, Genoa, Italy), 
and anti-CD31 (mouse 3'1) (a gift of Dr. C. Mackay, Basel Insti- 
tute for Immunology). Biotin-labeled mAbs were revealed with 
APC-streptavidin (Molecular Probes Inc., Eugene, OR), and un- 
labeled mAbs were revealed with PE-goat anti-mouse Ig subclass 
specific antisera (Southern Biotechnology Associates). Samples were 
analyzed on a FACStar Plus  |  Cytospin preparations of sorted cr 
CD4-8-  and CD4 §  + T cells were fixed with acetone and 
stained  with the anti-BCL-2  mAb 100 (22) followed by APAAP 
(Dako Corp.).  Cell cycle analysis was  performed using  7-AAD 
(Sigma Chemical Co., St. Louis, MO) in combination with WT31, 
anti-CD4, and -CD8 mAbs as described  (23). Samples were ana- 
lyzed on a FACScan  |  (Becton Dickinson & Co.), using an elec- 
tronic gate to exclude cell doublets. The DNA histograms were 
analyzed using a CELLFIT program (Becton Dickinson & Co.). 
Ascitic  fluid of antibodies to CDla (NA1/34),  CDlb (WM25), 
and CDlc (10C3)  was  donated by F.  Calabi  (Medical  Research 
Council, Cambridge,  UK). 
DNA Extraction and Blotting.  High molecular weight DNA was 
digested with EcoRI (New England Biolabs Inc., Beverly, MA), 
fractionated on 0.8% agarose gel and blotted to N-Hybond mem- 
brane (Amersham Corp., Arlington Heights, IL) according to stan- 
dard procedures (24). The probes were labeled (109 cpm//~g) using 
a random priming kit (Boehringer Mannheim, Mannheim, Ger- 
many). Filters were hybridized overnight at 68~  in 5x SSPE, 0.1% 
SDS,  1% BLOTTO, washed at 65~  in 0.1x  SSC, 0.1% SDS, 
and exposed. The TCR/3 locus probe was a 0.4-kb BglI fragment 
derived from the CB2 cDNA (25). The TCR 3, locus probe was 
a 0.7-kb HindlII-EcoRI J3'1 fragment (26). 
Anchor-primedPCR  Cloning and Sequencing.  Total KNA was ex- 
tracted from >5  x  106 cells as described (27). Single-strand cDNA 
was  synthesized  from  5  #g  total  RNA  using  oligo  (dT)12-1s 
primer and AMV reverse transcriptase  (Boehringer Mannheim). 
The anchor-primed PCK amplification was performed by a modifi- 
cation of a published method (28). The cDNA was ethanol precipi- 
tated three times and poly (dG) tailed in 40 #1 containing 0.1 mM 
dGTP and 15 U  terminal deoxitransferase  in the buffer supplied 
by the manufacturer (BILL, Gaithersburg,  MD) for 30 min at 37~ 
The cDNA was phenol extracted, ethanol precipitated, and resus- 
pended in 200 #1 of  water. 10 #1 of  each cDNA sample was amplified 
using 100 ng (about 15 pmol) of the following primers: a poly 
(dG) complementary primer 5'-GCATGCGCGCGCGGCCGC- 
GGAGG(C)14-3'  containing a SaclI  site,  together with either a 
TCK C/3 antisense  primer 5'TGCTGACCCCACTGTCGACCT- 
CCTTCCCATT-3' containing a  SalI site,  or with  a TCK Cc~ 
antisense primer 5'-CGTATCTGTTTCAAAGCTTTTCTCGAC- 
CAG-3',  containing a HindlII site. The amplifications  were per- 
formed in 30 #1 using a PCK kit (Perkin Elmer Corp., Norwalk, 
CT), with the following profile:  94~  for 15 s,  56~  for 60 s, 
60~  for 15 s, and 72~  for 45 s. The PCK products were digested 
either with SaclI plus Sall (TCR-B) or with SaclI plus HindlII 
(TCR-c0, cloned into pBluescript (Stratagene,  La Jolla, CA) and 
multiple isolates were sequenced.  The nomenclature of the TCK 
c~ and ~  genes is according to references  29-31. 
Limiting Dilution and PCR Oligotyping.  Total PBMC or sorted 
c~/~ DN cells were stimulated in a limiting dilution assay (LDA) 
as described above. Replicate cultures were grown to >5  x  106 
cells. Total RNA was extracted and 0.5/zg of it was reverse tran- 
scribed.  One tenth of the cDNA was amplified  in 30 #1, using 
80 ng of each primer. For the TCK/3 chain amplification,  the fol- 
lowing primers were used:  C~ 5'TGCTGACCCCACTGTCGA- 
CCTCCTTCCCATT-3', containing a SalI site, with either F20 VB 
5'-AGTACAGGATCCTATGGGAGCCT-3', containing a BamHI 
site, or CO9 VB 5'-GTGCGTCGACTATCAGGCTCCTCTGCT- 
ACAT-3', containing a SalI site. For the TCR c~ chain amplification, 
the primers were: Ca 5'-TGCTCTTGAATTCCATAGACCTCA- 
TGTC-3', which has an EcoRI site, with either F20 Vcr 5'-CTT- 
TTCAGTCGACACTCTGGTTCAAGC~-3', or CO9 Vc~ 5'-GAA- 
TACACAAGTCGACTC'IGGGAGC-3', both containing a Sail site. 
The PCR reactions were heated once for 2 rain at 94~  followed 
by 20 s at 60~  30 s at 72~  and 10 s at 94~  for 35 cycles, 
followed by a 10-min extension at 72~  10 #1 of each PCR reac- 
tion  were fractionated on 2%  agarose  gel,  alkaly blotted onto 
N-Hybond § nylon membrane, and hybridized on with 32p-labeled 
N region-specific oligonucleotides in 6 x  SSPE, 1% BLOTTO (dry 
skim milk), 1 mM EDTA, and 0.1% SDS. The filters were washed 
twice at room temperature in 6x  SSPE, 0.1% SDS for 10 min, 
once at the hybridization temperature for 10 min, and once at the 
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ing temperatures were determined in cell mixing experiments, in 
which the PCR oligotyping was performed on scaled numbers of 
the relevant clones  mixed with constant numbers of PHA blasts from 
unrelated donors. The oligonucleotides,  hybridization, and washing 
temperatures  were: F20 fl 5'-CATAGTCCCAAGCCCCTGAT- 
AGA-Y (50~  and 600C); F20 a  5'-GCTGCAGGATTTTCT- 
GGTGCCTA-Y (50~  and 600C); CO9/3 5'-TGAACTTGGGA- 
CTGAAGGAA-3' (40~  and 45~  and CO9 a  5'-GTGGTG- 
AGCGACAGAGGC-3'  (40~  and 48~  For tetanus toxoid (TT) 
specific CD4 + clones, replicated cultures were set in the presence 
of 10 #g/ml of TT (Connough,  Ontario, Canada) and expanded 
to '~2-3  x  l& cells. The KNA was extracted, the cDNA syn- 
thesized and amplified as described above, using the same Ca and 
CB oligonucleotides, plus one of the following V region oligonu- 
cleotides:  V~2  5'-GGACAGAATTCTCATCAACCATGCAAG- 
CCTGACCT-Y, containing an internal EcoRI site; Val 5'-ACC- 
CTGGTCGACGC~ATEAACGGTITIGA~A-3'; Va8 5'- 
GGCATTGTCGAC CATTC  GTTCAAATGTGGGCAAAAG-  Y; 
Va17 5'-CCAACAGTCGACTGGGAAAGGCCGTGCATTATT- 
GAT-Y; Va215'-CCAGCGTCGACAGCAAAATTCACCATCCC- 
TGAGCAG-3', all containing an internal SalI site. For N region 
oligotyping,  hybridization was carried out at 37~  as described 
above, using the following oligonucleotides  (20): clonotype AL15.1 
a  5'GCAGGGTCCTACAATGCCAGA-3' and/3 5'CTCCCC- 
CGGGGATACTATGGC-3'; ALp2III6.1 a  5'-GCAGCAAGC- 
GC~GGCCAGTTC-Y and 5'-AGA.TCGGACCCGC~TACAAGT- 
3'; ALp2III4.3 a  5'-GCAGCGACCTTGTATGGTCAG-Y  and/3 
5'-AGAGATCCGGGGGGGCAGGCGGGGTTT-3';  AL17.3 a 
5'-GCAGCAAGCAGCCGGAAACACA-Y and B 5'-CGAGCA- 
AGCCCTACCTACGAG-3'; AL4.1 a  5'-GCAGCTCGTCAGGG- 
CGGATCT-3' and  B 5'-AGGGGAGGGGGAAGGCCCCAG-Y; 
AL8.1 a  5'-GCAGCAGAGAATTATGGAGGA-Y  and/3 5'AAGA- 
CCGGGACTAGCAGATAC;  and AL9.2 a  5'-GTTGTGAGTGC- 
GGATACCGC~-Y and B 5'-AGAGGTCTCCCTGGGACTAGC-Y. 
Filters were washed twice for 15 min in 3 M Tetra methyl ammo- 
nium chloride (Sigma Chemical Co.), 50 mM Tris-HC1, pH 8.0, 
2 mM EDTA, 0.1% SDS at the stringent temperatures determined 
according to published  protocol (32): 63~  for all the 21-nucleotide- 
long N region 01igonucleotides, and 68~  for the 24-nucleotide- 
long ALp2III4.3 ~. The limiting dilution data were evaluated as 
described (33). 
PCR Cloning an Sequencing.  a/B DN T cell clones isolated 
in 1991 were PCR oligotyped and five positive clones from each 
donor were selected. The TCR-a and -B cDNAs were amplified, 
digested with the appropriate  restriction enzymes,  gel purified  using 
Prep-A-Gene matrix (Bio-Rad Laboratories, Richmond, CA), and 
ligated to pBluescript. The ligated product was electroporated  into 
JM105 bacteria and recombinant colonies were sequenced using 
Sequenase 2.0 (US Biochemical, Cleveland, OH). 
Results 
The Human  ot/fl  DN Subset  Contains Expanded  Clones. 
Four years ago, c~//3 DN T  cells were sorted from the pe- 
ripheral blood of two healthy individuals and immediately 
cloned by limiting dilution with high efficiency. The clones 
were characterized by Southern blot analysis using TCR C/31-2 
(25) and J3~1-2 probes (26),  and the results are summarized 
in Table  1.  In donor FO, who had 10%  cfffl DN T  cells 
in peripheral blood, 8/11 clones showed the same pattern of 
plus 3' rearrangement, suggesting that these cells might 
Table  1.  Clonal Relationship among Independently Isolated ot/d 
DN T  Cell Clones in Normal Individuals 
Donor  Percent a/B DN 
(age)  Year  T cells 
Frequency of clones sharing 
a unique TCR B plus 3' 
rearrangement pattern 
% 
FO (29)  1988  10  8/11  (73) 
CO (40) 1988  1  6/20 (30) 
6/20 (30) 
GC (30)  1991  2  2/11  (18) 
2/11  (18) 
2/11  (18) 
2/11  (18) 
PD (33)  1991  2  2/20 (10) 
2/20 (10) 
GS (39)  1991  2  0/20 
AL (42)  1991  1  0/20 
DN T cells were sorted from peripheral blood and cloned by limiting 
dilution (19). DNA was extracted  from  independent  clones, digested  with 
EcoRI, and analyzed  by Southern blot using C/~1-2 and J~/1-2 probes 
(24, 25). The frequency  of clones sharing the same ~ plus 3' rearrange- 
ment is shown. 
be clonally related. In donor CO, who had 1%  or//3 DN 
T  cells, two predominant clonotypes were found, each ac- 
counting for m30% of the DN clones. Four additional donors 
revealed a somewhat higher clonal heterogeneity: in two of 
them, GC and PD, identical patterns of rearrangements were 
found in four and two pairs of independent clones, whereas 
the remaining two donors showed distinct patterns in all the 
clones analyzed. Since the cells were not expanded in vitro 
before cloning, these findings suggest that the ot/B DN popu- 
lation of normal individuals often contains expanded clones 
of large size comprising 0.3-0.4%  and, in one individual, 
even 7%  of PBLs. 
The TCR ot and B genes from the two most frequent clono- 
types of donors FO and CO were cloned by anchor-primed 
PCR (28) and sequenced (Fig.  1). Clones F20 and CO9 ex- 
press different Vo~ and V~ and do not share any particular 
pattern in the N  region. Interestingly, the ot chain of CO9 
has a very short N  region (GAC) and is identical in the V, 
N,  and J  regions to an already published sequence  (34). 
Clonotype Identification by PCR Oligotyping.  Having the 
TCR-o~  and -B sequence,  it was possible,  using LDA and 
PCR olgiotyping, to determine the size and persistence  of 
these two clonotypes with time. Different numbers of PBMC, 
or sorted ot/~ DN cells, were stimulated in replicate cultures 
with PHA, feeder cells, and IL-2 and expanded to m5  x 
106 cells. To detect the presence of the clonotypic TCR tran- 
scripts,  RNA was extracted from each culture, reverse tran- 
scribed and amplified using Vot plus Co~ or V/~ plus CB oli- 
gonucleotides. The amplified products were fractionated on 
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Figure  1.  Sequences of the TCIL cr and/3 
genes from clonotypes F20 and CO9. The com- 
plete sequence was obtained by anchor-primed 
PCR. (27). The V andJ segments were already 
described  (28,  30).  Vc~LINV  corresponds  to 
Vex24 (28).  Shown is the junctional sequence. 
Oligonucleotides used for N region typing are 
underlined. 
an agarose gel, blotted, and hybridized with 32p-labeled N 
region-specific  oligonudeotides under high stringency con- 
ditions.  The system is very sensitive, allowing the detection 
of about 10 cells among 106 irrelevant lymphocytes (data not 
shown), and is highly specific. An example (Fig. 2 A) shows 
that the F20 clonotypic oligonucleotides  do not hybridize 
to amplified products of unrelated T cell clones or allogeneic 
PHA blasts. The only exception is the CO9 ot N region probe, 
which gives a signal in polyclonally  activated blasts from all 
individuals tested. This "invariant" ot chain is present in the 
peripheral blood of six out of six donors tested and is prefer- 
entially expressed in the cz//~ DN subset (Dellabona, P., manu- 
script in preparation). 
Detection of In  Vivo Expanded, Persistent cr/~ DN Clones. 
When 10 cr  DN clones isolated in 1991 from donor FO 
B 
PBMC/well 
s  lo  15  zo  2s  30 
0.37 
.01 
1988 F20 f-1:14 
PBMC/well 
s  lO  15  20  2s  30 
0.37.1  ............ 
7991  FZO f-1:14 
.01 
1 
0.37 
.1 
.01 
o~  CD4"8"/well 
2  4  6  B  10  12 
1991  C09 f,,I:4 
Figure  2.  Clonotypic frequency determined  by LDA-PCP..  (A) Example of oligotyping for the F20 clonotype performed on PCR-amplified  cz and 
B gene products  of 10 o~//~ DN clones  from donor  FO isolated in 1991, irrelevant control  clones  (GAATI8,  which shares the Vc~l.1  gene with F20, 
and ALp2,17), and allogeneic PHA blasts. ~-actin is used as control.  (Right) Size of the amplified products. (B) Frequency of the F20 and CO9 clonotypes 
estimated by LDA-PCP. oligotyping. The PCR oligotyping was performed three times.  Each point corresponds to 15-30 replicates. For b, the fraction 
of negative  wells (FO) at 5 cells/well  =  0.83,  at 25 cells/well  =  0.16;  in c FO at 5 cells/well  =  0.87,  at 25 cells/well  =  0.16;  in d Fo at 1 cell/well 
=  0.48,  at  10 cells/well  =  0.21. 
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that the frequency of the F20 clonotype after 4 yr was simi- 
larly high. As shown in Fig. 2 B, the frequency of clonotype 
F20, as measured by LDA, was one in 14 PBMC in samples 
frozen in 1988, and one in 14 PBMC in samples obtained 
in 1991, indicating that this expanded clonotype was also strik- 
ingly stable in size, composing ~7% of donable PBL over 
a 4-yr period. For clonotype CO9, the frequency determined 
in 1991 was one in four ~/~ DN cells, a frequency com- 
parable to the one estimated in 1988 by Southern blot anal- 
ysis of random c~//~ DN clones (Table 1). To confirm the 
specificity of the oligotyping, we cloned sorted ot/~ DN T 
cells from these donors in 1991, identified several new F20 
and CO9 clonotypes and sequenced the TCR c~ and j8 chains 
of five such T cell clones from each donor. All the sequences 
were identical to those of the original clones isolated in 1988, 
thus proving the persistence  of the nonmutated, expanded 
T  cell clones (data  not shown). 
Phenotype of  at/~ DN Clones In Viva  In view of the long 
persistence of F20 and CO9, it was of interest to investigate 
their functional status and phenotype. Three-color FACS  | 
analysis revealed that the ot/B DN population in these donors 
did not express high levels of early-intermediate activation 
markers such as CD69, CD25, CD38, and HLA-DR (data 
not shown). Interestingly, fresh ex vivo cells expressed  a 
CD45RA high, RO low phenotype (Fig. 3), whereas the cor- 
responding clones in culture acquired high levels of CD45R0 
(data not shown). Furthermore, in donor FO, the expanded 
o~/~ DN population expressed high levels of VLA-4 and CD29 
and low-intermediate levels of CD31 and leukocyte adhesion 
molecule (LAM) 1 (Fig. 4), a phenotype indicative of previous 
stimulation (35-38). 
F- 
R2  R3 ,  R.I 
~  ..~ 
￿9  "  '.: i  ~  "  ....  " 
.i  -:,.t? :.:  ., 
~  i~,  "  '  i~z  .....  i6.  ..... 
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CD45Re 
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II  m  I~ 
I co4 R.  r CD45RR 
~  iJ,  '  j~a  il,  g6. 
~  10.  sla  "  -  s~  '  t#. 
I OD4~A  Figure  3.  CD45 expression in freshly isolated c~/13 
T  cells of donor FO.  (/bp) Gates used for the three- 
color analysis: (R2) cx/~ DN, (R3) CD4 + , and (R4) 
CD8 +. In the histograms, the lower gate shows the 
percentage of positive cells in comparison to an isotype- 
matched irrelevant antibody, whereas the upper gate 
shows the percentage of cells expressing high levels 
of the marker. 
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Figure 4.  Expression of adhesion molecules VLA-4, CD29, CD31, and LAM-1 in freshly isolated ~/fl T cells of donor FO. The different populations 
were gated as in the upper panel of Fig. 3.  The percentage of positive cells is indicated. 
Cell cycle analysis of fresh PBMC  revealed  that <1%  of 
oe/3 DN cells were in the S-G2M phase (data not shown), 
The level of Bcl-2 expression in freshly sorted DN cells was 
comparable  to  that  of  the  CD4 +  and  CD8 +  peripheral 
blood T cells (data not shown). In conclusion, in peripheral 
blood,  the cells of the large and persisting ol//3 DN clones 
display a resting phenotype, with surface markers  typical of 
Ag-experienced  cells,  but with  CD45RA hi, R0 l~ 
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Since the ~/3 DN clones were selected with PHA, it is di~cult 
to identify the antigen that might have driven in vivo the 
donal expansion. When tested against a panel of target tumor 
cell lines,  we noticed that clone F20 killed Molt-4 and the 
killing could be inhibited by anti-CDla mAb as already de- 
scribed (Fig.  5 A,  17).  After the recent report by Porcelli 
et al. (18), we asked whether clone F20 might also recognize 
bacterial proteins.  We therefore expanded monocytes with 
GM-CSF and IL-4 (18) to obtain cells that express a high 
level of CD1. These cells were mitomycin C treated and cul- 
tured with F20 T cells in the presence or absence of bacterial 
antigens. As is evident from Fig. 5 B, both autologous and 
allogeneic CD1 + monocytes could stimulate proliferation of 
clone F20 in the presence of heat-killed E. coll. Addition of 
anti CD1 mAbs caused only a modest inhibition of prolifer- 
ation, which was, however, more clear with anti-CDla. These 
findings raise the possibility that CDla alone or associated 
with bacterial antigens may be the stimulus for the clonal 
expansion and persistence of F20 in vivo. 
Clonal Size  and Persistence of Antigen-specific CD4 + T 
Cells.  To ask whether large clonal size and persistence are 
unique features of oe/3 DN cells, we analyzed the frequen- 
cies and persistence of clones specific for a TT epitope in a 
donor who was repeatedly boosted with this vaccine. 
As previously reported  (20),  several ol/3 CD4 + T  cell 
clones specific for the TT 830-844 were isolated from inde- 
pendent cultures in 1989. The frequency of TT-specific cells 
in peripheral blood was ~one in 3,000 and all the clones, 
except two, were unrelated as determined by TCR-oe and "3 
sequences. After 2 yr, 200 replicate cultures were stimulated 
with TT,  each containing 10  s PBMC,  and the responding 
cells from the individual cultures were expanded and ana- 
lyzed by PCR oligotyping to detect the presence of seven 
clonotypes that had been isolated in 1989. Although in con- 
trol cell mixing experiments we were able to detect the signal 
of 10 cells of a given clonotype in a million of allogeneic 
PBMC,  none of the seven clonotypes could be identified 
among the TT-specific cells expanded 2 yr later (data not 
shown). This experiment shows that the class II-restricted 
response to a single epitope is highly polyclonal, and that 
each of the clones has a very small clonal size. Thus, large 
donal size and persistence are not the key features of an antigen- 
specific response, at least in the CD4 + compartment. 
Discussion 
Our analysis represents, to our knowledge, the first sys- 
tematic attempt to measure in vivo the clonal expansion and 
persistence of T  cells. We have used PCR oligotyping and 
limiting dilution analysis to measure the frequency of clones 
within  the ot//3 DN  and oe/3 CD4 +  subset.  Two major 
findings emerge from this study. First, the ol/3 DN subset 
contains expanded clones that can account for up 0.5% and, 
in one donor, even 7% of PBL. Second, the expanded clones 
can persist for up to 4 yr with comparable size and a pheno- 
type that is noncycling, CD45RA  hi RO  I~ and  VLA-4  hi. 
The size of these oe/3 DN clones is remarkable. Since PBL 
are "o5  x  109, the size of these clones varies from 5  x  106 
to  4  x  108, but  is  certainly underestimated,  since most 
('~,98%) of all T  lymphocytes are outside the blood (39). 
It is possible that ol/3 DN T  ceils are compartmentalized 
in peripheral lymphoid or nonlymphoid organs such as liver, 
bone marrow, and LN in mice (5,  6) and skin in humans 
(40), and it is therefore possible that in peripheral blood we 
are measuring only a selected fraction of the clones. 
The cx/3 DN expanded clones in the blood are noncycling 
and express  a CD45RA hi KO  l~ phenotype. Since the same 
ceils switch to RO hi when activated in vitro, it is conceiv- 
able that they may have reverted to RA  hi sometimes after 
being activated (41-44). Indeed, when isolated from the blood, 
the expanded clones express high levels of ol4/31  integrins 
and low levels of t-selectin and CD31, a phenotype that has 
been attributed to memory T ceils (37, 38). This phenotype 
resembles that of cx/3 DN cells in autoimmune MRL-Mp- 
lpr/Ipr mice (45) or in transgenic mice, where od3 DN ceils 
expand and persist in the presence of a self-antigen (9). 
How can such a large clonal size be maintained and what 
is the driving force for clonal expansion? To explain the per- 
sistence of expanded clones, we can consider two mechanisms. 
First, the clones may have expanded once by antigenic stim- 
ulation and subsequently persist in a resting state for 4 yr 
as long-lived memory cells that have reverted their CD45R0 
phenotype to RA. Alternatively, these clones may undergo 
continuous expansion in peripheral organs (for instance in 
the intestine, where they are exposed to E. coli antigens), and 
the ceils that revert to the resting state may reenter the recir- 
culating pool,  while others may die. 
The lack of CD4 and CD8 coreceptors would suggest that 
these cells may not recognize classical class I or II molecules. 
Indeed, it has been shown that some human ~/[3 DN T cell 
clones recognize CDla molecules as such or CDlb in associ- 
ation with bacterial antigens (17,  18; clone F20). It is pos- 
sible that chronic stimulation with a common bacterial an- 
tigen such as E. coli  may drive a sustained proliferation resulting 
in a large clonal expansion as is the case for clone F20. 
An alternative and testable possibility is that the clones 
may recognize self-MHC molecules and the affinity of rec- 
ognition may be tuned by fluctuating levels of CD4 or CD8 
molecules, as has been shown in a transgenic model (46). 
The oligoclonal expansion and persistence of c~/3 DN T 
cells is in striking contrast with our finding that oe//3 CD4 § 
clones specific for a TT peptide epitope are present at low 
frequency (<1 in 107) and cannot be detected in a sample of 
2  x  107 lymphocytes after 2 yr. Although the characteriza- 
tion ofT cell donal size and persistence in the oe/3 SP subset 
is quite preliminary and outside the scope of this work, it 
seems to fit the current paradigms of immune response and 
memory, i.e.,  polyclonality (20)  and requirement for con- 
tinuous antigenic stimulation to maintain a memory cell pool 
(47,  48). 
Contrary to our results with oe/3 CD4 + clones, which 
conform to current models of T  cell response, the observa- 
tion with DN clones is unexpected. The oligoclonal expan- 
1769  Ddlabona  et al. sions in this subset could be explained if the T  cell repertoire 
for a putative selecting antigen is small. Alternatively, these 
cells could be expanded and maintained by different mech- 
anisms. 
These results suggest that o~/B DN T  cells may represent 
a  separate lineage with  rules of selection and dynamics in 
periphery different from the SP.  In some aspects,  the cr 
CD4-8-  subset  resembles  B1  (Ly-1)  B  cells,  which  are 
known to be created once in ontogeny, persist because of self- 
renewal capacity, and recognize self as well as common en- 
vironmental antigens  (49-51). 
We thank Mark Dessing for help with the cell cycle analysis; David Mason for providing the anti-BCb2 
mAb; Drs. D. Mathis, W. Gehrard, K. Karjalainen,  C. Mackay, and H. yon Boehmer for critically reading 
the manuscript; and G. De Libero and S. Abrignani for helpful discussions. 
The Basel Institute for Immunology was founded and is supported by F. Hoffmann-La Roche & Co. 
Ltd, Basel,  Switzerland. 
Address correspondence to Dr. Paolo Dellabona, DIBIT, H.S. Raffaele, Via Olgettina 58, 20132 Milano, 
Italy. Alan Tunnacliffe is currently at CRC Human Cancer Gen., Department of Pathology, University 
of Cambridge, Tennis Court Road, Cambridge CB1  1QP, UK. 
Received for publication 8January  1993 and in revised form 24 February 1993. 
~l~rences 
1.  Z~niga-Pfl~cker, J.C., L.A. Jones, L.T. Chin, and A.M. F~'uis- 
beek. 1991. CD4 and CD8 act as co-receptors during thymic 
selection of T  celI repertoire. Sere. Immunol. 3:167. 
2.  Fowlkes, B.J., A.M. Kruisbeck, H. Ton-That, M.A. Weston, 
J.E. Coligan, R.H. Schwartz, and D.M. Pardoll. 1987. A novel 
population of T-cell receptor cff/~-bearing thymocytes which 
predominantly express a single V3 gene family. Nature (Lond.). 
319:251. 
3.  Londei, M., A. Verhoef, P. Debernardinis, M. Kissonerghis, 
B.G. Loebenstein, and M. Feldman. 1989. Definition of a popu- 
lation of CD4- 8- T cells that express the c~//~ T-cell receptor 
and respond to intefleukins 2, 3, and 4. Proc. Natl. Acad. Sci. 
USA. 86:8502. 
4.  Levitsky, H.I., P.T. Golumbek, and D.M. Pardoll.  1991. The 
fate of CD4-8-  T cell receptor-s/B § thymocytes.J. Immunol. 
146:1113. 
5.  Seki,  S., T. Abo, T. Ohteki,  K. Sugiura, and K. Kumagai. 
1991. Unusual cr//5-T cells expanded in autoimmune lpr mice 
are probably a counterpart of normal T  cells in the liver. J. 
Immunol. 147:1214. 
6.  Palathumpat, V., S. Dejbakhsh-Jones, B. Holm, H. Wang, O. 
Liang, and S. Strober. 1992. Studies of CD4- CD8- or/3 bone 
marrow T cells with suppressor activity.J. Immunol. 148:373. 
7.  Andreu-S~nchez, J.L., I. Moreno de Albor~n, M.A.R. Marcos, 
A. S~nchez-Movilla,  C. Martlnez-A., and G. Kroemer. 1991. 
Interleukin 2 abrogates the nonresponsive state of T cells ex- 
pressing a forbidden T cell receptor repertoire and induces au- 
toimmune disease in neonatally thymectomized mice. J. Exp. 
Med. 173:1323. 
8.  Huang, L., and N. Crispe. 1992. Distinctive selection mecha- 
nisms  govern  the  T  cell  receptor repertoire of peripheral 
CD4-CD8-  c~/[3 T  cells. J. Exl~ Med. 176:699. 
9.  von Boehmer, H., J. Kirberg, and R  Ikocha.  1990. An un- 
usual lineage ofo~/B T cells contains autoreactive cells.J. Exp. 
Med. 174:1001. 
10.  Robey, E.A., F. Ramsdell, J.W. Gordon, C. Mamalaki,  D. Ki- 
ussis, H.J. Youn,  P.D. Gottlieb, R. Axel, and B.J. Fowlkes. 
1992. A self reactive T cell population that is not subject to 
negative selection. Int. Immunol. 4:969. 
11.  Cohen, P.L., and IL.A. Eisenberg. 1992. The Ipr and gld genes 
in systemic autoimmunity: life and death in the Fas lane. lm- 
munol, Today. 13:427. 
12.  Ohteki, T., S. Seki, T. Abo, and K. Kumagai. 1990. Liver is 
a possible  site for the proliferation of abnormal CD3+4-8- 
double negative lymphocytes in autoimmune MRLIt,  r/llor mice. 
J. Exp. Med. 172:7. 
13.  Wirt, D.P., E.G. Brooks, S. Vaidya, G. Klimpel, T.A. Wald- 
mann, and R.M. Goldblum. 1989. Novel T-lymphocytes popu- 
lation in combined immunodeficiency with features of graft- 
versus-host  disease. N. Engl. J. Med. 321:370. 
14.  Shivakumar,  S., G.C.  Tsokos,  and S.K.  Datta.  1989.  T  cell 
receptor cff3 expressing double-negative (CD4-/CD8-)  and 
CD4 + T helper cells in humans augment the production of 
pathogenetic anti-DNA autoantibodies associated with lupus 
nephritis. J. Immunol. 143:103. 
15.  Kubota, H., H. Okazaki, M. Onuma, S. llano, M. Hattori, 
and  N.  Minato.  1992.  CD3+4-8 -  c~/3  T  cell population 
with biased T cell receptor V gene usage.J. Immunol. 149:1143. 
16.  Abo, T., T. Ohteki, S. Seki,  N. Koyamada,  Y. Yoshikai,  T. 
Masuda,  H. Rikiishi, and K. Kumagai. 1991. The appearance 
of T cells bearing self reactive T cell receptor in the livers of 
mice injected with bacteria. J. Exp. Med. 174:417. 
17.  Porcelli, S., M.B. Brenner, J.L. Greenstein, S.P. Balk, C. Terhost, 
and P.A. Bleicher. 1989. Recognition of cluster of differentia- 
tion 1 antigens by human CD4-CD8-  cytolyfic T lympho- 
cytes. Nature (Lond.). 341:447. 
18.  Porcelli, S., C.T. Morita, and M.R Brenner.  1992. CDlb re- 
stricts the response of human CD4-8-  T  lymphocytes to a 
microbial antigen. Nature (Lond.). 360:593. 
19.  Lanzavecchia, A.  1985. Antigen specific interaction between 
1770  Persistence  of Expanded Clones Specific for Bacterial Antigens T  and B cells. Nature (Lond.). 314:537. 
20.  Boitel, B., M. Ermonval, P. Panina-Bordignon, R.A.  Mari- 
uzza, A. Lanzavecchia, and O. Acuto. 1992. Preferential V3 
gene usage and lack of  junctional sequence conservation among 
human T cell receptors specific for tetanus toxin-derived pep- 
tide: evidence for a dominant role of a germline encoded V 
region in antigen/major histocompatibility complex recogni- 
tion. j. Extx  Med.  175:765. 
21.  A. Lanzavecchia.  1986.  Is the T  cell receptor involved in T 
cell killing? Nature (Lond.). 319:778. 
22.  Pezzella,  F., A.G.D. Tse, J.L. Cordell, K.A.F. Pulford, K.C. 
Gatter, and D.Y. Mason.  1990. Expression of the Bcl-2 on- 
cogene protein is not specific for the 14;18 chromosomal trans- 
location. Am. J. Pathol. 137:225. 
23.  Schmid, I., C.H. Uittenbogaart, and J.V. Giorgi. 1991. A gentle 
fixation and permeabilization method for combined cell sur- 
face and intracellular staining with improved precision in DNA 
quantification. Cytometry.  12:279. 
24.  Sambrook, J., E.F. Fritsch, and T. Maniatis.  1989. Molecular 
Cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, 
NY. 
25.  Yoshikai, Y., A. Anatoniou, S. Clark, Y. Yanagi, K. Sangster, 
P. Elsen,  C. Terhost, and T.W. Mak. 1984. Sequence and ex- 
pression of transcripts of the human TCR 3 chain genes. Na- 
ture (Lond.). 312:521. 
26.  Lefranc, M.P., and T.H. Rabbits.  1985. Two tandemly orga- 
nized human genes encoding the T cell 3' constant-region se- 
quences show multiple rearrangement in different T-cell types. 
Nature (Lond.). 316:464. 
27.  Chomczynski, P., and N. Sacchi.  1987.  Single-step  method 
of KNA isolation by acid guanidinium thiocyanate-phenol- 
chloroform extraction. Anal.  Biochem.  162:156. 
28.  I.oh, E.Y., J.F. Eliott, S. Cwirla, L.L. Lanier, and M.M. Davis. 
1989. Polymerase chain reaction with single-sided  specificity: 
analysis of T cell receptor ~ chain. Science (Wash. DC). 243:217. 
29.  Roman-Roman, S., L. Ferradini,  J.  Azocar,  C. Genevee, T. 
Hercend, and F. Triebel.  1991. Studies on the T cell receptor 
c~/~ variable region genes I. Identification of 7 additional Vc~ 
subfamilies and 14 Jc~ gene segments. Eur.J. Immunol.  21:927. 
30.  Ferradini,  L., S. Roman-Roman, J. Azocar, H. Michalaki,  F. 
Triebel,  and T. Hercend. 1991. Studies on the human T cell 
receptor ot/[3 variable region genes II. Identification of four 
additional V~ subfamilies. Eur. j.  Immunol.  21:935. 
31.  Toyonaga,  B., and T.W. Mak.  1987.  Genes of the T-cell an- 
tigen receptor in normal and malignant T  cells. Annu.  Rev. 
Immunol.  5:585. 
32.  Wood, W.I., J. Gitschier,  L.A. Lasky, and R.L. Lawn. 1985. 
Base composition-independent hybridization in tetramethylam- 
monium chloride: a method for oligonucleotide screening of 
highly complex gene libraries. Proc. Natl. Acad. Sci. USA. 82: 
1585. 
33.  Lefkovits, I., and H. Waldmann.  1979. Limiting Dilution Anal- 
ysis of Cells in the Immune System.  Cambridge University 
Press,  Cambridge, UK. 
34.  Mengle-Gaw, L., H.F. Willard,  C.I.E. Smith. L. Hammar- 
strom, P. Fischer, P. Sherrington, G. Lucas, P.W. Thompson, 
K. Baer, and T.H. Rabbits. 1987. Human T-cell tumors con- 
taining chromosome 14 inversion or translocation with break- 
points proximal to immunoglobulin joining regions at 14q32. 
EMBO (Eur. MoI. Biol. Organ.) J.  6:2273. 
35.  Hemler, M.E. 1990. VLA proteins in the integrin family: struc- 
tures, function, and their role on leukocytes. Annu. Rev. Ira- 
munot. 8:365. 
36.  Dustin, M.L., and T.A. Springer.  1991. Role of lymphocytes 
adhesion  receptors in transient interactions and cell locomo- 
tion. Annu.  Rev. Immunol.  9:27. 
37.  Shimizu, Y., W. Newman, Y. Tanaka, and S. Shaw. 1992. Lym- 
phocyte interactions with endothelial cells. Immunol.  Today. 
13:106. 
38.  Mackay, C.R.  1992.  Migration pathways  and immunologic 
memory among T  lymphocytes. Sem. Immunol.  4:51. 
39.  Westermann, J., and R. Pabst.  1990. Lymphocyte subsets in 
the blood: a diagnostic window on the lymphoid system? Im- 
munol.  Today. 11:406. 
40.  Groh, V., M. Fabbi, F. Hochstenbach, K.T. Maziarz, andJ.L. 
Strominger.  1989. Double negative (CD4-CD8-)  lympho- 
cytes bearing T-cell receptor c~ and B chains in normal skin. 
Proc. Natl. Acad. Sci. USA.  86:5059. 
41.  Bell, E.B., and S.M. Sparshott. 1990. Interconversion of CD45R. 
subsets  of CD4 T  cells in vivo. Nature (Lond.). 348:163. 
42.  Kothstein, D.M., S. Sohen, J.F. Daley, S.F. Schlossman,  and 
C. Morimoto. 1990. CD4+CD45RA + and CD45RA-  T cell 
subsets in man maintain distinct function and CD45RA ex- 
pression persists on a subpopulation of CD45RA + cells after 
activation with Con A. Cell. Immunol.  129:449. 
43.  Warren, H.S., and L.J. Skipsey. 1991. Loss of activation-induced 
CD45K0 with maintenance of CD45RA expressing prolonged 
culture of T  cells and NK cells. Immunology.  74:78. 
44.  Michie, C.A., A. McLean, C. Alcock, and P.C.L. Beverly. 1992. 
Lifespan of human lymphocytes subset defined by CD45 iso- 
forms. Nature (Lond.). 360:264. 
45.  Smyth, L., M. Howell, and I.N. Crispe.  1992. Self reactivity 
and the expression of memory markers vary independently in 
MRL-Mp+/+  and MR_U  Mp-Ipr/lpr mice. Deu lmmunol. 2:309. 
46.  von Boehmer, H. 1992. Thymic selection: a matter of life and 
death. Immunol.  Today. 13:454. 
47.  Gray, D., and P. Matzinger. 1991. T cell memory is short lived 
in the absence of antigen. J. Extx Med.  174:969. 
48.  Oehen, S., H. Waldner,  T.M. Kfindig, H. Hengartner, and 
R.M. Zingernagel. 1992. Antivirally protective T cell memory 
to lymphocytic  choriomeningitis virus is governed by persisting 
antigen, j.  Exp.  Med.  176:1273. 
49.  Hayakawa, K., and R.R. Hardy. 1988. Normal, autoimmune, 
and malignant CD5 § B cells: the LY-1 B lineage. Annu. Rev. 
Immunol.  6:197. 
50.  Forster, I., H. Gu, and K. Rajewsky. 1988. Germline antibody 
regions as determinants of clonal persistence  and malignant 
growth in the B cell compartment. EMBO (Fur. Mol.  Biol. 
Organ.) J.  7:3693. 
51.  Kipps,  T.J.  1989. The CD5 B cells. Adv. Immunol.  46:117. 
1771  Dellabona  et al. 